Hans Sollinger, M.D., Ph.D., Founder and Chief Science Officer Oct. 14 | 9:45am | BlueRock Therapeutics Ballroom Madison, WI (Private) In-person Presentation Endsulin is a preclinical gene therapy company focused on advancing its lead clinical candidate to treat Diabetes mellitus. Endsulin’s novel technology aims to give millions of people greater...

Rachel Diamant, Chief Intellectual Property Officer and Head of Pipeline Development Oct. 12 | 10:45am | BlueRock Therapeutics Ballroom Miami, FL (Private) In-person Presentation EmendoBio is a pioneering, next-generation CRISPR company. Our unique approach allows us to make any gene targetable, transforming the current landscape of genetic medicine. Founded and...

Ryan Pruchnic, Managing Vice President Oct. 13 | 9:15am | BlueRock Therapeutics Ballroom Pittsburgh, PA (Private) In-person Presentation In 2002, Cook MyoSite was formed to guide the Cook Group organization into the expanding world of cellular technologies through the development and subsequent commercialization of technology related to the collection, selection,...

Marie Csete, M.D., Ph.D., CEO Oct. 13 | 11:30am | BlueRock Therapeutics Ballroom Pasadena, CA (Private) In-person Presentation ConeSight Therapeutics is a biotech company dedicated to developing cell-based therapies for blinding diseases, based on discoveries in the lab of Dr. Michael Young at Harvard Medical School. The first product is...

Joon Lee, Ph.D., Senior Vice President and Chief Business Officer Oct. 12 | 4:00pm | BlueRock Therapeutics Ballroom Seongnam-si, Republic of Korea (Private) In-person Presentation Cellatoz Therapeutics is a biotech company with strong expertise in translational research and process development. Equipped with its proprietary cells and commercialization-ready GMP facility in...

Alvin Shih, M.D., CEO Oct. 12 | 2:00pm | BlueRock Therapeutics Ballroom Cambridge, MA (Private) In-person Presentation Catamaran Bio is developing transformative off-the-shelf CAR-NK cell therapies to realize the full potential of cell therapy by powering a key type of immune cell, natural killer cells, with new properties to create...

Seth Ettenberg, Ph.D., Chief Scientific Officer Oct. 12 | 2:15pm | AVROBIO Ballroom Cambridge, MA (Private) In-person Presentation BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. The company’s cell+gene platform enables the creation, manufacture, and delivery of authentic cell therapies...

Dusty Tenney, President and Chief Operating Officer Oct. 13 | 9:30am | BlueRock Therapeutics Ballroom Bothell, WA (NASDAQ: BLFS) In-person Presentation BioLife Solutions is a leading developer, manufacturer, and supplier of class-defining cell and gene therapy bioproduction tools and services. Our solutions facilitate basic and applied research and commercialization of...

Robert Mays, Ph.D., Vice President of Regenerative Medicine Oct. 12 | 3:00pm | AVROBIO Ballroom Cleveland, OH (NASDAQ: ATHX) In-person Presentation Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of...

Ryan Gill, Ph.D., CEO Oct. 12 | 1:45pm | BlueRock Therapeutics Ballroom Louisville, CO (Private) In-person Presentation Artisan Bio’s vision is to design, build, and deliver cells, precision engineering processes, and therapeutic candidates that advance cellular therapies across a broad range of human health indications. The company’s designer cell engineering...

By using this website you agree to accept our Privacy Policy and Terms & Conditions